CONVEYXO
Founded in 2019 by Dr Jean Paul Prieels (former Senior VP R&D GSK Biologicals), ConvEyXO is an advanced pre-clinical stage Belgian biotech company developing a Therapeutic Portfolio in anti-inflammatory and aging-related diseases (#Biotech), built on our proprietary Technology Platform (#Deeptech) which harnesses exosomes derived from immortalized cell lines and enhances the properties of exosomes in specific indications by loading target-specific miRNAs.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}